2025-03-11 03:40:12
Latest Post
NTPC Group to Invest Rs 96,000 Crore in Chhattisgarh
Arvind Fashions aims to expand its CLUB A stores across India
Somany Ceramics Elevates Luxury with the launch of Duragres 2025 Collection
Cosmo Films Bags SIES SOP Star Awards 2025 for Innovative Packaging Materials
Zaggle Prepaid Ocean Services Ltd receives 'Financial Institution of the Year' Award
Stock Report
Glenmark Life Sciences Ltd Q4 FY2024 PAT declines to Rs. 97.93 crores
Posted On : 2024-04-25 15:49:39( TIMEZONE : IST )
Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 539.728 crores during the period ended March 31, 2024 as compared to Rs. 574.495 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 97.937 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 118.765 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 7.97 for the period ended March 31, 2024 as compared to Rs. 9.67 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹539.728 crs | ₹574.495 crs |  -6.05% |
| Net Profit | ₹97.937 crs | ₹118.765 crs | -17.54% |
| EPS | ₹7.97 | ₹9.67 | -17.58% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs.539.728 crores during the period ended March 31, 2024 as compared to Rs.624.156 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.97.937 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.146.357 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.7.97 for the period ended March 31, 2024 as compared to Rs.11.94 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹539.728 crs | ₹624.156 crs | -13.53% |
| Net Profit | ₹97.937 crs | ₹146.357 crs | -33.08% |
| EPS | ₹7.97 | ₹11.94 | -33.25% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.2295.256 crores during the Financial Year ended March 31, 2024 as compared to Rs.2190.177 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.470.888 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.466.961 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.38.38 for the Financial Year ended March 31, 2024 as compared to Rs.38.11 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹2295.256 crs | ₹2190.177 crs |  4.80% |
| Net Profit | ₹470.888 crs | ₹466.961 crs | 0.84% |
| EPS | ₹38.38 | ₹38.11 | 0.71% |
Shares of Glenmark Life Sciences Ltd was last trading in BSE at Rs. 826.20 as compared to the previous close of Rs. 827.30. The total number of shares traded during the day was 4643 in over 542 trades.
The stock hit an intraday high of Rs. 837.55 and intraday low of 824.05. The net turnover during the day was Rs. 3857579.00.
